The Australasian Ocular Melanoma Alliance (AOMA) held an educational gathering in Hobart on the 7th of March.

Led by MASC Trials and Dr Malaka Ameratunga, the BETTER trial aims to improve the care, treatment and quality of life for symptomatic patients with melanoma that has spread to the brain.

To help conquer the urgent problem Australia has with melanoma and skin cancer, leading skin care brand Avène has teamed up with Melanoma and Skin Cancer Trials.

The incredible efforts of the team behind Conquering Skin Cancer were recognised at the 2025 Impact DOCS Awards with Awards of Excellence for Best Documentary Feature and Best Direction. There are also new screening locations and sessions to be held in in South Australia and New South Wales.

Melanoma and Skin Cancer Trials has been chosen by the Australian Livestock and Property Agents Association (ALPA) as its 2024 charity.

Melanoma and Skin Cancer Trials and the Victorian Heart Institute are leading an Australian-first trial to determine if a common cholesterol medication can reduce the risk of heart attacks in melanoma patients treated with cancer therapy.

A $110,000 donation to a new trial treating melanoma brain metastases will help open additional research sites around Australia, offering hope to patients, like Peter Wilson, who have melanoma that has spread to the brain.

MASC Trials, MSCAN and BlazeAid have partnered to deliver sun safety educational videos for BlazeAid volunteers so they know how to protect their skin during frontline disaster response work.

Digital photography combined with artificial intelligence technology has shown promising results as a diagnostic tool for the early detection of melanoma.